Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07786077
What this trial is testing

Patients' Preferences for Primary Immune Thrombocytopenia Treatment

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 100
Post-approval studies (Phase 4)Study completedNCT01472718
What this trial is testing

Thromboaspiration in Patients With High Thrombotic Burden Undergoing Primary Percutaneous Coronary Intervention (PCI)

Who this might be right for
Primary PCI for STEMI
University of Pisa 208
Not applicableUnknownNCT06485583
What this trial is testing

Comparison Between the Efficacy of CIMT and NDT Along With Conventional Physiotherapy Treatment on Upper Extremity Rehabilitation Among Patients of Stroke

Who this might be right for
Strokes Thrombotic
Shalamar Institute of Health Sciences 10
Testing effectiveness (Phase 2)UnknownNCT05932524
What this trial is testing

Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 132
Testing effectiveness (Phase 2)Study completedNCT04346654
What this trial is testing

Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 26
Testing effectiveness (Phase 2)Ended earlyNCT04128956
What this trial is testing

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS

Who this might be right for
Venous ThrombosesStent Stenosis
University of Zurich 172
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Not applicableStudy completedNCT01280630
What this trial is testing

Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients

Who this might be right for
Acute Coronary Syndrome
AstraZeneca 500
Early research (Phase 1)Ended earlyNCT00244257
What this trial is testing

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Genzyme, a Sanofi Company 10
Not applicableUnknownNCT00843804
What this trial is testing

Surveillance for Nosocomial Infections in Pediatric Cancer Patients

Who this might be right for
Nosocomial InfectionsBloodstream InfectionInvasive Aspergillosis
University Hospital, Bonn 50
Not applicableLooking for participantsNCT07347990
What this trial is testing

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyHematopoietic Stem Cell Transplantation (HSCT)
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)UnknownNCT05415150
What this trial is testing

Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic

Who this might be right for
Acute Ischemic Stroke
Baylor College of Medicine 30
Large-scale testing (Phase 3)WithdrawnNCT04274452
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
argenx
Not applicableStudy completedNCT04825548
What this trial is testing

Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol

Who this might be right for
Acute Lymphoblastic LeukemiaPost Thrombotic Syndrome
Aarhus University Hospital 27
Not applicableStudy completedNCT06038682
What this trial is testing

Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure

Who this might be right for
ARDSCOVID-19
University Hospital Ostrava 100
Not applicableUnknownNCT03465020
What this trial is testing

Investigation on a Dynamic Cohort of Italian Patients With Active ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Gruppo Italiano Malattie EMatologiche dell'Adulto 861
Large-scale testing (Phase 3)Study completedNCT00699140
What this trial is testing

Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura
Instituto Grifols, S.A. 18
Not applicableUnknownNCT04913597
What this trial is testing

Switching Avatrombopag and Rh-TPO in ITP

Who this might be right for
Corticosteroid-resistant or Relapsed ITP
Peking University People's Hospital 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT05046106
What this trial is testing

MLC1501 Study Assessing Efficacy in STROke Recovery

Who this might be right for
StrokeStroke, IschemicStrokes Thrombotic+4 more
Moleac Pte Ltd. 540
Not applicableUnknownNCT00006055
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

Who this might be right for
Purpura, Schoenlein-HenochGraft Versus Host DiseaseAnemia, Hemolytic, Autoimmune+11 more
Fairview University Medical Center 10
Next Page